Synthesis, Spectral Characterization and In-Vitro Biological Evaluation of Novel 5-Methoxy / 5-Ethoxy Benzimidazole-2-Thiol Derivatives as Antibacterial, Antifungal, Anti-tubercular and Antioxidant Agents

Authors

  • Dheeraj Kumar tiwari
  • Rajasekaran S

Keywords:

Benzimidazole-2-thiol derivatives, N-aryl acetamides, S-alkylation, Antibacterial activity, Antifungal activity, Antitubercular screening, Antioxidant activity, Molecular docking, Structure–activity relationship (SAR), Heterocyclic drug design

Abstract


 The present study focuses on the design, synthesis, spectral characterization, and comprehensive in-vitro biological evaluation of a novel series of 2-(5-substituted-1H-benzimidazol-2-ylthio)-N-arylacetamide derivatives (SS1–SS21), developed to explore their antibacterial, antifungal, antitubercular, and antioxidant potential. The synthetic strategy involved S-alkylation of 5-methoxy, 5-ethoxy, and 5-chloro benzimidazole-2-thiols with appropriately substituted N-(chloroacetyl) aryl amines, affording the target compounds in good yields. Structural elucidation was achieved through FT-IR, ¹H-NMR, mass spectrometry, melting point analysis, and TLC profiling, all confirming the successful formation of the designed thioether-linked N-aryl acetamides. Antibacterial assays performed against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, and Bacillus subtilis revealed that several derivatives, particularly nitro- and chloro-substituted analogues, exhibited MIC values comparable to or better than ampicillin. Antifungal evaluation against Candida albicans, Aspergillus niger, Epidermophyton floccosum, Trichophyton rubrum, and wild Penicillium spp. demonstrated that methoxy- and ethoxy-substituted derivatives displayed strong fungicidal activity, in several cases approaching or surpassing Griseofulvin and nearing Nystatin efficacy. Antitubercular screening against Mycobacterium tuberculosis H37Rv identified SS5 and SS15 as moderately active, which correlated well with molecular docking studies showing favourable binding energies and key interactions with cyclopropane-fatty-acyl-phospholipid synthase enzymes (PDB: 1KPG, 1KPI). Antioxidant assessment using the DPPH assay revealed potent radical-scavenging properties for electron-donating methoxy and ethoxy derivatives, especially SS9 and SS10. Structure–activity relationship analysis indicated that electron-withdrawing substituents enhanced antibacterial potency, while electron-donating groups favored antifungal and antioxidant effects. Overall, the study presents benzimidazole-2-thiol-based N-aryl acetamides as promising multifunctional agents with significant antimicrobial and antioxidant potential, offering valuable scaffolds for future optimization and drug development..

Downloads

Download data is not yet available.

References

1. Hobrecker F. Ber Deutsch Chem Ges, Berlin. 1872;5:920–4.

2. Hodgkin DG, Pickworth J, Robertson JH, Trueblood KN, Prosen RJ, White JG. The crystal structure of the hexacarboxylic acid derived from B12. Nature. 1955;176:325–8.

3. Raeymaekers AH, Van Gelder JL, Roevens LF, Janssen PA. Synthesis and anthelmintic activity of alkyl-(5-acyl-1H-benzimidazol-2-yl)carbamates. Arzneimittel-Forschung. 1978;28:586–94.

4. Theodorides VJ, Gyurik RJ, Kingsbury WD, Parish RC. Anthelmintic activity of albendazole. Experientia. 1976;32:702–3.

5. Pene P, Mojon M, Garin JP, Coulaud JP, Rossignol JF. Albendazole: broad-spectrum anthelmintic. Am J Trop Med Hyg. 1982;31:263–6.

6. Ries U, Kauffmann I, Hauel N, Priepke H, Nar H, Stassen JM, et al. Benzimidazoles: production and medicinal use. WO Patent 2000/001704 A2.

7. Janssen PA, Niemegeers CJ, Schellekens KH, Marsboom RH, Herin VV, Amery WK, et al. Bezitramide: a potent long-acting analgesic. Arzneimittel-Forschung. 1971;21:862–7.

8. Hunger A, Kebrle J, Rossi A, Hoffmann K. Synthesis of analgesically active benzimidazole derivatives. Experientia. 1957;13:400–1.

9. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, et al. Potent angiotensin II antagonist benzimidazole derivative CV-11974. J Pharmacol Exp Ther. 1993;266:114–20.

10. Ogihara T, Nagano M, Mikami H, Higaki J, Kohara K, Azuma J, et al. Effects of TCV-116 in humans. Clin Ther. 1994;16:74–86.

11. Clemons GP, Sisler H. Mode of action of fungitoxic benomyl derivative. Pestic Biochem Physiol. 1971;1:32–43.

12. Jerchel D, Fischer H, Kracht M. Zur Darstellung der Benzimidazole. Justus Liebigs Ann Chem. 1952;575:162–73.

13. Gupta S, Pancholi SS, Gupta MK, Agrawal D, Khinchi MP. Synthesis and biological evaluation of 2-substituted benzimidazoles. J Pharm Sci Res. 2010;2.

14. Patil S, Bhatt P, Suryawanshi H, Patil J, Chaudhari R. Substituted benzimidazole derivatives: synthesis & biological evaluation. Chem Proc. 2021;8.

15. Raka SC, Rahman A, Hussain F, Rahman SMA. Synthesis, characterization and biological evaluations of benzimidazole derivatives. Saudi J Biol Sci. 2022;29:239–50.

16. Avila-Sorrosa A, Gil-Ruiz LA, Vargas-Diaz ME, Torres-Nogueda B, Morales-Morales D. Green synthesis & anticancer evaluation of benzimidazoles. Results Chem. 2025;14:102134.

17. Hadole CD, Rajput JD, Bendre RS. Biologically important 2-substituted benzimidazoles: concise review. Org Chem Curr Res. 2018;7:195.

18. Miao TT, Tao XB, Li DD, Chen H, Jin XY, Geng Y, et al. 2-Aryl-benzimidazole derivatives as tubulin inhibitors. RSC Adv. 2018;8:17511–26.

19. Kumar S, Sati MD, Sati SC. Synthesis and biological evaluation of benzimidazole derivatives. IOSR-JAC. 2024;17:13–18.

20. Deshmukh HS, Adole VA, Mali SN, Jagdale BS. 2-Aryl benzoimidazo-thiazole sulfonamides as antitubercular agents. BMC Chem. 2025;19:126.

21. Nisha K, Nathiya P, Kumar SN, Nethaji M. Benzimidazole and nitrated derivatives: synthesis and biological evaluation. IJNRD. 2023;8:767–772.

22. Verma R, Gupta C, Ganie AM, Kumar V, Singh S, Singh PK. Chemistry of benzimidazole derivatives: mini review. IJMPR. 2021;5:167–197.

23. Habibi A, Valizadeh Y, Mollazadeh M, Alizadeh A. Green synthesis of 2-aryl benzimidazoles. Int J Org Chem. 2015;5:256–263.

24. Karaaslan Ç. New benzimidazole amidoxime derivatives: synthesis & structure elucidation. Turk J Pharm Sci. 2020;17:108–114.

25. Anas M, Kumar A, Singh K, Hasan SM, Kushwaha SP, et al. Benzimidazole as antimicrobial agents: systematic review. Ann Phytomed. 2022;11:102–113.

26. Mohammed LA, Farhan MA, Dadoosh SA, et al. Benzimidazole heterocycles: synthesis & medicinal applications. SynOpen. 2023;7:e20230031.

27. Unnisa A, Huwaimel B, Almahmoud S, et al. Pyrazol-benzimidazole hybrids as lipase inhibitors. Eur Rev Med Pharmacol Sci. 2022;26:7245–7255.

28. Coulibaly S, Evrard A, Kumar A, Sissouma D. Benzimidazoles & imidazopyridines: synthesis & biological profiles. ChemRxiv. 2023.

29. Nandha B, Nargund LG, Nargund SL, Bhat K. Fluorobenzimidazoles as antitubercular agents. Iran J Pharm Res. 2017;16:929–942.

30. Huang CC, Smith CV, Glickman MS, Jacobs WR Jr., Sacchettini JC. Crystal structures of mycolic acid cyclopropane synthases. J Biol Chem. 2002;277:11559–69.

31. Rajasekhar S, Maiti B, Balamurali M, Chanda K. Benzimidazole synthesis and medicinal applications. Curr Org Synth. 2017;14:40–60.

32. Rani S, Salahuddin, Mazumder A, Kumar R, et al. Pyrazole/pyrazoline-bearing benzimidazoles: therapeutic exploration. Curr Org Chem. 2025.

33. Babbar R. Therapeutic potential of Schiff and Mannich bases of 2-substituted benzimidazoles. Int J Drug Del Technol. 2022.

34. Ouaket A, Moughaoui F, Laaraibi A, et al. DPPH scavenging of bis-benzimidazole derivatives. Med J Chem. 2019;8:103–107.

35. Gaba M, Mohan C. Drug development with imidazole & benzimidazole heterocycles. Med Chem Res. 2016;25:173–210.

.

Downloads

Published

2025-12-16

How to Cite

1.
tiwari DK, S R. Synthesis, Spectral Characterization and In-Vitro Biological Evaluation of Novel 5-Methoxy / 5-Ethoxy Benzimidazole-2-Thiol Derivatives as Antibacterial, Antifungal, Anti-tubercular and Antioxidant Agents. J Neonatal Surg [Internet]. 2025 Dec. 16 [cited 2026 Jan. 20];14(33S):59-80. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9697

Issue

Vol. 14 No. 33S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.